These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 21500096

  • 1. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
    Kartal M, Saydam G, Sahin F, Baran Y.
    Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
    [Abstract] [Full Text] [Related]

  • 2. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB, Ural AU, Avcu F, Baran Y.
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [Abstract] [Full Text] [Related]

  • 3. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
    Camgoz A, Gencer EB, Ural AU, Avcu F, Baran Y.
    Leuk Lymphoma; 2011 Aug; 52(8):1574-84. PubMed ID: 21756066
    [Abstract] [Full Text] [Related]

  • 4. Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells.
    Bassoy EY, Baran Y.
    Biomed Pharmacother; 2012 Mar; 66(2):103-10. PubMed ID: 22326625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.
    Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B.
    J Biol Chem; 2007 Apr 13; 282(15):10922-34. PubMed ID: 17303574
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.
    Tian H, Yu Z.
    Int J Clin Exp Pathol; 2015 Apr 13; 8(3):2755-62. PubMed ID: 26045781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M, Apohan E, Baran Y.
    Cancer Chemother Pharmacol; 2013 Jan 13; 71(1):13-20. PubMed ID: 23073611
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR, Williams JB.
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep 13; 163(1):26-36. PubMed ID: 22613819
    [Abstract] [Full Text] [Related]

  • 15. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J, Grundy M, Shang S, Russell N, Pallis M.
    Exp Hematol; 2005 Jan 13; 33(1):62-72. PubMed ID: 15661399
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells.
    Yamane M, Miyazawa K, Moriya S, Abe A, Yamane S.
    Biochimie; 2011 Sep 13; 93(9):1446-59. PubMed ID: 21571032
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor.
    Guan S, Liu YY, Yan T, Zhou J.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):230-236. PubMed ID: 27221045
    [Abstract] [Full Text] [Related]

  • 19. Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes.
    Inoue C, Sobue S, Mizutani N, Kawamoto Y, Nishizawa Y, Ichihara M, Takeuchi T, Hayakawa F, Suzuki M, Ito T, Nozawa Y, Murate T.
    Nagoya J Med Sci; 2020 May 05; 82(2):261-280. PubMed ID: 32581406
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.